Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma

@article{Mller2009ElectrochemotherapyAA,
  title={Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma},
  author={M. M{\"o}ller and S. Salwa and D. Soden and G. O'sullivan},
  journal={Expert Review of Anticancer Therapy},
  year={2009},
  volume={9},
  pages={1611 - 1630}
}
  • M. Möller, S. Salwa, +1 author G. O'sullivan
  • Published 2009
  • Medicine
  • Expert Review of Anticancer Therapy
  • Treatment of recurrent or in-transit unresectable melanoma continues to be a major therapeutic challenge. Electrochemotherapy (ECT) is a therapeutic option for those patients whose lesions are not suitable for surgical resection and who have exhausted all other treatment modalities. ECT combines electroporation of tumor cells with the administration either of intravenous or intratumoral antineoplastic drugs, such as bleomycin or cisplatin. The cell membranes are thus rendered permeant to these… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    A new approach to treating solid tumours (both operable and inoperable) has been carried out by the Cork Cancer Research Centre (CCRC) at the Mercy University Hospital, Cork, Ireland… Expand
    ConditionsColorectal Cancer
    InterventionDevice
    Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach
    • 114
    Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis
    • 42
    • PDF
    Intralesional immunotherapy as a strategy to treat melanoma
    • 11

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 195 REFERENCES
    Bases and rationale of the electrochemotherapy
    • 153